Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Juvenile 2Inflammation 2Asthma 2Wilms Tumor 1Vasculitis 1Uveitis 1Temporomandibular Joint Disorders 1Stomatitis 1Spondylitis, Ankylosing 1Respiratory Distress Syndrome 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lupus Nephritis 1Lung Injury 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Immunoglobulin Light-chain Amyloidosis 1Granulomatosis with Polyangiitis 1Fatigue Syndrome, Chronic 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Bronchiolitis Obliterans 1Blast Crisis 1

Interventions

Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Bronchiolitis Obliterans × Etanercept × Clear all
NCT00141726 2015-12-03

Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

University of Michigan Rogel Cancer Center

Phase 2 Completed
34 enrolled 13 charts

Bronchiolitis Obliterans, Respiratory Distress Syndrome, Lung Injury, Acute Lung Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡